• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨转移癌患者治疗评估方法

Methodology for treatment evaluation in patients with cancer metastatic to bone.

作者信息

Cook R J, Major P

机构信息

Department of Statistics and Actuarial Science, University of Waterloo, ON, Canada.

出版信息

J Natl Cancer Inst. 2001 Apr 4;93(7):534-8. doi: 10.1093/jnci/93.7.534.

DOI:10.1093/jnci/93.7.534
PMID:11287447
Abstract

BACKGROUND

Patients with cancer metastatic to bone experience several adverse and clinically important skeletal-related events, including pathologic fractures, vertebral compressions with fracture, the need for surgery to treat or prevent fractures, and the need for radiation therapy for the treatment of bone pain. We present appropriate methods for describing and modeling the clinical course of skeletal-related events and comparing treatments for such events.

METHODS

On the basis of data from a recently completed randomized, placebo-controlled trial involving 380 breast cancer patients with bone metastases, we tested the validity of the "events-per-person-years" method, one of the most commonly used techniques, for the analysis of skeletal-related events. We then used more robust methods of analysis that are based on fewer assumptions, including a random-effects Poisson model, and contrasted the inferences about skeletal-related event rates and treatment effects for the different analytic methods. All statistical tests were two-sided.

RESULTS

The events-per-person-years analysis underestimated substantially the variation in the data and is not appropriate to summarize the incidence rate of skeletal-related events. A random-effects Poisson model did provide a valid basis for analyzing such data.

CONCLUSIONS

The underestimation of variability in data associated with the use of the events-per-person-years analysis leads to unduly narrow confidence intervals for complication rates and inflated false-positive error rates in treatment comparisons. A random-effects Poisson model provides a valid, robust basis for describing the clinical course of bone complications and evaluating treatment effects.

摘要

背景

发生骨转移的癌症患者会经历多种不良且具有临床重要性的骨相关事件,包括病理性骨折、伴有骨折的椎体压缩、治疗或预防骨折所需的手术,以及治疗骨痛所需的放射治疗。我们提出了描述和模拟骨相关事件临床病程以及比较此类事件治疗方法的合适方法。

方法

基于一项近期完成的涉及380例乳腺癌骨转移患者的随机、安慰剂对照试验的数据,我们测试了“每人年事件数”方法(最常用的技术之一)用于分析骨相关事件的有效性。然后,我们使用了基于较少假设的更稳健分析方法,包括随机效应泊松模型,并对比了不同分析方法对骨相关事件发生率和治疗效果的推断。所有统计检验均为双侧检验。

结果

“每人年事件数”分析大幅低估了数据的变异性,不适用于总结骨相关事件的发生率。随机效应泊松模型确实为分析此类数据提供了有效的基础。

结论

与使用“每人年事件数”分析相关的数据变异性低估导致并发症发生率的置信区间过窄,以及治疗比较中假阳性错误率过高。随机效应泊松模型为描述骨并发症的临床病程和评估治疗效果提供了有效、稳健的基础。

相似文献

1
Methodology for treatment evaluation in patients with cancer metastatic to bone.骨转移癌患者治疗评估方法
J Natl Cancer Inst. 2001 Apr 4;93(7):534-8. doi: 10.1093/jnci/93.7.534.
2
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2002(1):CD003474. doi: 10.1002/14651858.CD003474.
3
Understanding treatments for bone loss and bone metastases in patients with prostate cancer: a practical review and guide for the clinician.了解前列腺癌患者骨质流失和骨转移的治疗方法:临床医生实用综述与指南
Urol Clin North Am. 2004 May;31(2):331-52. doi: 10.1016/j.ucl.2004.01.001.
4
Retrospective database analysis of the effect of zoledronic acid on skeletal-related events and mortality in women with breast cancer and bone metastasis in a managed care plan.回顾性数据库分析唑来膦酸在管理式医疗计划中乳腺癌伴骨转移女性骨骼相关事件和死亡率中的作用。
J Med Econ. 2012;15(1):175-84. doi: 10.3111/13696998.2011.632044. Epub 2011 Nov 8.
5
Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials.伊班膦酸钠治疗转移性骨病的综述:来自III期试验的经验。
Clin Ther. 2004 Dec;26(12):1947-59. doi: 10.1016/j.clinthera.2004.12.010.
6
Bisphosphonates for advanced prostate cancer.双膦酸盐用于晚期前列腺癌。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD006250. doi: 10.1002/14651858.CD006250.
7
Clinical trials in metastatic breast cancer to bone: past--present--future.转移性乳腺癌骨转移的临床试验:过去——现在——未来
Can J Oncol. 1995 Dec;5 Suppl 1:16-27.
8
Incidence of skeletal-related events over time from solid tumour bone metastases reported in randomised trials using bone-modifying agents.随机试验中使用骨改良药物报告的实体瘤骨转移所致骨骼相关事件的随时间发生率。
Clin Oncol (R Coll Radiol). 2013 Jul;25(7):435-44. doi: 10.1016/j.clon.2013.03.003. Epub 2013 Apr 10.
9
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨药物。
Cochrane Database Syst Rev. 2012 Feb 15(2):CD003474. doi: 10.1002/14651858.CD003474.pub3.
10
American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel.美国临床肿瘤学会关于双膦酸盐在乳腺癌中作用的指南。美国临床肿瘤学会双膦酸盐专家小组。
J Clin Oncol. 2000 Mar;18(6):1378-91. doi: 10.1200/JCO.2000.18.6.1378.

引用本文的文献

1
Accuracy of artificial intelligence in detecting tumor bone metastases: a systematic review and meta-analysis.人工智能检测肿瘤骨转移的准确性:一项系统评价和荟萃分析。
BMC Cancer. 2025 Feb 18;25(1):286. doi: 10.1186/s12885-025-13631-0.
2
Effect of Minimally Invasive Spine Stabilization in Metastatic Spinal Tumors.微创脊柱稳定术治疗转移性脊柱肿瘤的效果。
Medicina (Kaunas). 2022 Mar 1;58(3):358. doi: 10.3390/medicina58030358.
3
Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT.
初级保健中的防跌倒干预措施以减少 70 岁及以上人群的骨折和跌倒:PreFIT 三臂群组 RCT。
Health Technol Assess. 2021 May;25(34):1-114. doi: 10.3310/hta25340.
4
Liaison Treatment for Metastatic Spinal Tumors.转移性脊柱肿瘤的联合治疗
Spine Surg Relat Res. 2020 Mar 19;4(3):223-228. doi: 10.22603/ssrr.2019-0105. eCollection 2020.
5
Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience.8 Gy单次分割姑息性放射治疗对疼痛性骨转移瘤的疗效:单机构经验
Cureus. 2018 Jan 8;10(1):e2036. doi: 10.7759/cureus.2036.
6
Bisphosphonates and other bone agents for breast cancer.用于乳腺癌的双膦酸盐及其他骨治疗药物。
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD003474. doi: 10.1002/14651858.CD003474.pub4.
7
AAPT Diagnostic Criteria for Chronic Cancer Pain Conditions.美国物理医学与康复学会慢性癌症疼痛病症诊断标准。
J Pain. 2017 Mar;18(3):233-246. doi: 10.1016/j.jpain.2016.10.020. Epub 2016 Nov 21.
8
Exploiting machine learning for predicting skeletal-related events in cancer patients with bone metastases.利用机器学习预测骨转移癌患者的骨相关事件。
Oncotarget. 2016 Mar 15;7(11):12612-22. doi: 10.18632/oncotarget.7278.
9
Hemi body irradiation: An economical way of palliation of pain in bone metastasis in advanced cancer.半身照射:晚期癌症骨转移疼痛姑息治疗的一种经济方法。
South Asian J Cancer. 2014 Jan;3(1):28-32. doi: 10.4103/2278-330X.126513.
10
Optimal management of bone metastases in breast cancer patients.乳腺癌患者骨转移的最佳治疗管理。
Breast Cancer (Dove Med Press). 2011 May 2;3:35-60. doi: 10.2147/BCTT.S6655.